Your browser doesn't support javascript.
Covid-19 and the role of smoking: the protocol of the multicentric prospective study COSMO-IT (COvid19 and SMOking in ITaly).
Cattaruzza, Maria Sofia; Gorini, Giuseppe; Bosetti, Cristina; Boffi, Roberto; Lugo, Alessandra; Veronese, Chiara; Carreras, Giulia; Santucci, Claudia; Stival, Chiara; Pacifici, Roberta; Zagà, Vincenzo; Gallus, Silvano; Giulietti, Federico; Sarzani, Riccardo; Spannella, Francesco; Del Donno, Mario; Tartaglione, Stefania; Marrazzo, Giuseppina; Pelaia, Girolamo; D'Agosto, Vincenzo; Berti, Alice; Voller, Fabio; Cardellicchio, Salvatore; Cresci, Chiara; Foschino Barbaro, Maria Pia; De Palma, Raffaele; Negrini, Simone; Sicbaldi, Vera; Serafini, Antonella; Bisconti, Mario; Refolo, Leonida; Landoni, Giovanni; Rovere, Patrizia; Veronesi, Giulia; Faverio, Paola; Garavello, Werner; Pesci, Alberto; Giacobbe, Raffaella; Martucci, Paola; Parrella, Roberto; Scarano, Francesco; Aiello, Marina; Chetta, Alfredo; Franco, Cosimo; Mangia, Angelo; Carrozzi, Laura; Maggi, Fabrizio; Monzani, Fabio; Pistelli, Francesco; Russo, Patrizia.
  • Cattaruzza MS; Dipartimento di Sanità Pubblica e Malattie Infettive Sapienza Università di Roma. mariasofia.cattaruzza@uniroma1.it.
  • Gorini G; Oncologic network, prevention and research Institute (ISPRO), Florence, Italy . g.gorini@ispro.toscana.it.
  • Bosetti C; Department of Oncology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy. cristina.bosetti@marionegri.it.
  • Boffi R; Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy. roberto.boffi@istitutotumori.mi.it.
  • Lugo A; Department of Environmental Health Sciences, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy. alessandra.lugo@marionegri.it.
  • Veronese C; Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy. chiara.veronese@istitutotumori.mi.it.
  • Carreras G; Oncologic network, prevention and research Institute (ISPRO), Florence, Italy . giulia.carreras@gmail.com.
  • Santucci C; Department of Oncology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy. claudia.santucci@marionegri.it.
  • Stival C; Department of Environmental Health Sciences, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy. chiara.stival@marionegri.it.
  • Pacifici R; National Observatory on Smoking, Alcohol and Drugs, National Institute of Health, Rome, Italy. roberta.pacifici@iss.it.
  • Zagà V; Italian Society of Tobaccology (SITAB), Italy. vincenzo.zaga@icloud.com.
  • Gallus S; Department of Environmental Health Sciences, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy. silvano.gallus@marionegri.it.
  • Giulietti F; Ospedali Riuniti di Torrette di Ancona, Ancona. f.giulietti@inrca.it.
  • Sarzani R; Ospedali Riuniti di Torrette di Ancona, Ancona. sarzani@univpm.it.
  • Spannella F; Ospedali Riuniti di Torrette di Ancona, Ancona. f.spannella@univpm.it.
  • Del Donno M; AORN "S.Pio"-P.O. "G.Rummo", Benevento. mario.deldonno@gmail.com.
  • Tartaglione S; AORN "S.Pio"-P.O. "G.Rummo", Benevento. dr.stefaniatartaglione@gmail.com.
  • Marrazzo G; Policlinico Universitario Magna Graecia, AO Mater Domini. giusimarrazzo@gmail.com.
  • Pelaia G; Policlinico Universitario Magna Graecia, AO Mater Domini. pelaia@unicz.it.
  • D'Agosto V; Ospedale di Eboli, Salerno. v.dagosto@aslsalerno.it.
  • Berti A; ARS Toscana, Firenze. alice.berti@ars.toscana.it.
  • Voller F; ARS Toscana, Firenze. fabio.voller@ars.toscana.it.
  • Cardellicchio S; Azienda Ospedaliera Universitaria Careggi, Firenze. s.cardellicchio@alice.it.
  • Cresci C; Azienda Ospedaliera Universitaria Careggi, Firenze. crescic@aou-careggi.toscana.it.
  • Foschino Barbaro MP; Policlinico Riuniti, Foggia. mariapia.foschino@unifg.it.
  • De Palma R; Policlinico S. Martino, Genova. raffaele.depalma@unige.it.
  • Negrini S; Policlinico S. Martino, Genova. negrini@unige.it.
  • Sicbaldi V; Policlinico S. Martino, Genova. verasicbaldi@gmail.com.
  • Serafini A; Ospedale di Imperia, ASL 1 Imperiese, Imperia. serafini.antonella@vodafone.it.
  • Bisconti M; Ospedale Vito Fazzi, Lecce. bisconti.mario@libero.it.
  • Refolo L; Ospedale Vito Fazzi, Lecce. dimref@tiscali.it.
  • Landoni G; Ospedale San Raffaele, Milano. landoni.giovanni@hsr.it.
  • Rovere P; Ospedale San Raffaele, Milano. rovere.patrizia@hsr.it.
  • Veronesi G; Ospedale San Raffaele, Milano. veronesi.giulia@hsr.it.
  • Faverio P; Ospedale San Gerardo, Monza. paola.faverio@gmail.com.
  • Garavello W; Ospedale San Gerardo, Monza. werner.garavello@unimib.it.
  • Pesci A; Ospedale San Gerardo, Monza. a.pesci@asst-monza.it.
  • Giacobbe R; A.O.R.N. A. Cardarelli, Napoli. raffaela.giacobbe@gmail.com.
  • Martucci P; A.O.R.N. A. Cardarelli, Napoli. paola.martucci@aocardarelli.it.
  • Parrella R; Ospedale Domenico Cotugno, Napoli. rob.parrella@gmail.com.
  • Scarano F; Ospedale Domenico Cotugno, Napoli. scaranofrancesco66@gmail.com.
  • Aiello M; Azienda Ospedaliero Universitaria di Parma, Parma. marina.aiello@unipr.it.
  • Chetta A; Azienda Ospedaliero Universitaria di Parma, Parma. chetta@unipr.it.
  • Franco C; Ospedale Guglielmo da Saliceto, Piacenza. c.franco@ausl.pc.it.
  • Mangia A; Ospedale Guglielmo da Saliceto, Piacenza. a.mangia@ausl.pc.it.
  • Carrozzi L; Azienda Ospedaliero- Universitaria Pisana, Pisa. laura.carrozzi@unipi.it.
  • Maggi F; Azienda Ospedaliero- Universitaria Pisana, Pisa. fabrizio.maggi63@gmail.com.
  • Monzani F; Azienda Ospedaliero- Universitaria Pisana, Pisa. fabio.monzani@med.unipi.it.
  • Pistelli F; Azienda Ospedaliero- Universitaria Pisana, Pisa. f.pistelli@ao-pisa.toscana.it.
  • Russo P; Azienda Ospedaliero- Universitaria Pisana, Pisa. patrizia_russo@hotmail.it.
Acta Biomed ; 91(3): e2020062, 2020 08 27.
Article in English | MEDLINE | ID: covidwho-761263
ABSTRACT
The emergency caused by Covid-19 pandemic raised interest in studying lifestyles and comorbidities as important determinants of poor Covid-19 prognosis. Data on tobacco smoking, alcohol consumption and obesity are still limited, while no data are available on the role of e-cigarettes and heated tobacco products (HTP). To clarify the role of tobacco smoking and other lifestyle habits on COVID-19 severity and progression, we designed a longitudinal observational study titled COvid19 and SMOking in ITaly (COSMO-IT). About 30 Italian hospitals in North, Centre and South of Italy joined the study. Its main aims are 1) to quantify the role of tobacco smoking and smoking cessation on the severity and progression of COVID-19 in hospitalized patients; 2) to compare smoking prevalence and severity of the disease in relation to smoking in hospitalized COVID-19 patients versus patients treated at home; 3) to quantify the association between other lifestyle factors, such as e-cigarette and HTP use, alcohol and obesity and the risk of unfavourable COVID-19 outcomes. Socio-demographic, lifestyle and medical history information will be gathered for around 3000 hospitalized and 700-1000 home-isolated, laboratory-confirmed, COVID-19 patients. Given the current absence of a vaccine against SARS-COV-2 and the lack of a specific treatment for -COVID-19, prevention strategies are of extreme importance. This project, designed to highly contribute to the international scientific debate on the role of avoidable lifestyle habits on COVID-19 severity, will provide valuable epidemiological data in order to support important recommendations to prevent COVID-19 incidence, progression and mortality.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Pandemics / Betacoronavirus / Tobacco Smoking / Life Style Type of study: Cohort study / Observational study / Prognostic study Topics: Vaccines Limits: Female / Humans / Male Country/Region as subject: Europa Language: English Journal: Acta Biomed Journal subject: Medicine Year: 2020 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Pandemics / Betacoronavirus / Tobacco Smoking / Life Style Type of study: Cohort study / Observational study / Prognostic study Topics: Vaccines Limits: Female / Humans / Male Country/Region as subject: Europa Language: English Journal: Acta Biomed Journal subject: Medicine Year: 2020 Document Type: Article